Conferences & Events

Found 112,677 articles

• Medigene AG to present at upcoming May 2023 investor conferences

  5/8/2023

  Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the following upcoming investor conferences:

• Opthea To Present at the JMP Securities Life Sciences Conference

  5/8/2023

  Opthea Limited announced that Timothy E. Morris, the Company’s Chief Financial Officer will present at the JMP Securities Life Sciences Conference being held in New York City on May 15-16 2023.

• Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023

  5/8/2023

  Mallinckrodt plc, a global specialty pharmaceutical company, announced the presentation of results from two clinical studies for adults with hepatorenal syndrome with rapid reduction in kidney function1 treated with TERLIVAZ® for injection at Digestive Disease Week® 2023, taking place in Chicago, Ill.

• Transcenta to Present Two Clinical Trial Progress at ASCO 2023

  5/8/2023

  Transcenta Holding Limited announces that two posters for clinical trials of its ADCC enhanced anti-CLDN18.2 monoclonal antibody Osemitamab in combination with CAPOX or CAPOX plus Nivolumab for first-line G/GEJ cancer will be presented at 2023 American Society of Clinical Oncology Annual Meeting.

• CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023

  5/8/2023

  CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023, and will host a corporate update conference call at 4:30pm Eastern Time.

• Dentsply Sirona to Participate in Upcoming Investor Conferences

  5/8/2023

  DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced its participation at upcoming conferences.

• Kintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference

  5/8/2023

  Kintara Therapeutics, Inc. today announced that its President and CEO, Robert E. Hoffman , will present a corporate overview at the Sidoti Micro-Cap Virtual Conference being held on May 10 – 11, 2023.

• Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates

  5/8/2023

  Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, May 15, 2023 at 8:30 a.m. Eastern Daylight Time to review first-quarter 2023 financials and provide corporate updates.

• PharmAbcine to participate in BIO International Convention 2023

  5/8/2023

  PharmAbcine Inc. announced today that the company will participate in the upcoming BIO International Convention 2023.

• Inhibikase Therapeutics to Report First Quarter Financial Results on May 15, 2023

  5/8/2023

  Inhibikase Therapeutics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023, after the close of U.S. markets.

• DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

  5/8/2023

  DiaMedica Therapeutics Inc. announced today that its first quarter 2023 financial results will be released after the markets close on Monday, May 15th.

• HeartSciences to Participate at the Inaugural EF Hutton Global Conference

  5/8/2023

  Heart Test Laboratories, Inc. today announces that CEO, Andrew Simpson, will participate at the Inaugural EF Hutton Global Conference being held May 10 – 11, 2023, at the Plaza Hotel in New York City.

• Benitec Biopharma to Present at the JMP Securities Life Sciences Conference

  5/8/2023

  Benitec Biopharma Inc. today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec will present at the JMP Securities Life Sciences Conference on Tuesday, May 16th, 2023 at 2:00 pm.

• AltruBio Announces Poster Presentation at Digestive Disease Week Conference 2023

  5/8/2023

  AltruBio Inc. today announced that David T. Rubin, M.D., Professor of Medicine and Pathology at the University of Chicago and AltruBio Scientific Advisory Board member, will share a poster presentation on immune checkpoint enhancer (ICE), ALTB-168, during  Digestive Disease Week®, taking place at McCormick Place in Chicago, IL, from May 6-9, 2023.

• Cerevance to Present at the 2023 RBC Capital Markets Global Healthcare Conference

  5/8/2023

  Cerevance today announced that Craig Thompson, chief executive officer of Cerevance, will present at the upcoming 2023 RBC Capital Markets Global Healthcare Conference being held May 16-17, 2023.

• Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023Management to Host Conference Call

  5/8/2023

  Minerva Neurosciences, Inc. today announced that it will release first quarter 2023 financial results and business updates on Monday, May 15, 2023.

• Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023Live conference call on Friday, May 12 at 8:30 a.m. ET

  5/8/2023

  Longeveron Inc. today announced that the Company will release its first quarter 2023 financial results on Friday, May 12, 2023 before the open of the U.S. financial markets.

• Rallybio to Present at the JMP Securities 2023 Life Sciences Conference

  5/8/2023

  Rallybio Corporation today announced that company management will participate in a fireside chat at the JMP Securities 2023 Life Sciences Conference on Monday, May 15 at 2:30 p.m. ET in New York, NY.

• Cognito Therapeutics Announces Poster Presentations at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023 Meeting

  5/8/2023

  Cognito Therapeutics announced today two poster presentations at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023 Meeting, held May 7-10 in Boston, MA.

• Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference

  5/8/2023

  Bio-Rad Laboratories, Inc. today announced that the company’s management will participate in a fireside chat event during the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023, at 3:35 PM Eastern Time (12:35 PM Pacific Time).